Immune thrombocytopenic purpura

被引:22
|
作者
Zainal, Abir [1 ]
Salama, Amr [1 ]
Alweis, Richard [1 ]
机构
[1] Rochester Reg Hlth, Unity Hosp, Dept Med, 1555 Long Pond Rd, Rochester, NY 14626 USA
关键词
Immune thrombocytopenic purpura; hematology; platelets; corticosteroids;
D O I
10.1080/20009666.2019.1565884
中图分类号
R5 [内科学];
学科分类号
1002 ; 100201 ;
摘要
Immune thrombocytopenic purpura (ITP) is a bleeding disorder characterized by isolated thrombocytopenia (platelet count <150,000u/L), which is not associated with a systemic illness. ITP is reported in approximately 2 per 100,000 adults. The mean age of diagnosis is 50years. ITP is more common in females of childbearing age and in pregnancy. In adults, the course is more chronic although spontaneous remission can also occur within months of initial diagnosis. A thorough and timely workup of thrombocytopenia is imperative to rule out other differentials of ITP as it is considered a diagnosis of exclusion. Primary care physicians encounter patients who exhibit signs of thrombocytopenia such as petechiae or purpura on a regular basis. A high index of clinical suspicion is required to accurately diagnose ITP and commence the appropriate treatment including glucocorticoids to increase the chances of a favorable prognosis as described by the authors.
引用
收藏
页码:59 / 61
页数:3
相关论文
共 50 条
  • [41] Review of therapies for immune thrombocytopenic purpura
    Bussel, James
    Tarantino, Michael
    SEMINARS IN HEMATOLOGY, 2006, 43 (03) : S1 - S2
  • [42] RITUXIMAB AS TREATMENT OF IMMUNE THROMBOCYTOPENIC PURPURA
    Ferreira, D.
    Pires, T.
    Machado, N.
    CLINICAL THERAPEUTICS, 2015, 37 (08) : E127 - E127
  • [43] Daratumumab for immune thrombotic thrombocytopenic purpura
    van den Berg, Jana
    Hovinga, Johanna A. Kremer
    Pfleger, Claudia
    Hegemann, Inga
    Stehle, Gregor
    Holbro, Andreas
    Studt, Jan-Dirk
    BLOOD ADVANCES, 2022, 6 (03) : 993 - 997
  • [44] Flow cytometry and immune thrombocytopenic purpura
    Goubran, Hadi
    Hart, Caroline
    Othman, Ibraheem
    Seghatchian, Jerard
    TRANSFUSION AND APHERESIS SCIENCE, 2018, 57 (06) : 800 - 803
  • [45] Treatment of acute immune thrombocytopenic purpura
    Tarantino, MD
    Goldsmith, G
    SEMINARS IN HEMATOLOGY, 1998, 35 (01) : 28 - 35
  • [46] PREGNANCY AND IMMUNE THROMBOCYTOPENIC PURPURA - REPLY
    SCOTT, JR
    ROTE, NS
    CRUIKSHANK, DP
    AMERICAN JOURNAL OF OBSTETRICS AND GYNECOLOGY, 1984, 149 (02) : 240 - 240
  • [47] DANAZOL THERAPY IN IMMUNE THROMBOCYTOPENIC PURPURA
    MARWAHA, RK
    SINGH, RP
    GAREWAL, G
    MARWAHA, N
    PRAKASH, D
    SARODE, R
    PEDIATRIC HEMATOLOGY AND ONCOLOGY, 1990, 7 (02) : 193 - 198
  • [48] Immune thrombocytopenic purpura: Pathophysiology and treatment
    Godeau, B.
    TRANSFUSION CLINIQUE ET BIOLOGIQUE, 2009, 16 (02) : 101 - 105
  • [49] IMMUNE THROMBOCYTOPENIC PURPURA - CURRENT CONCEPTS
    TARDIO, DJ
    MCFARLAND, JA
    GONZALEZ, MF
    JOURNAL OF GENERAL INTERNAL MEDICINE, 1993, 8 (03) : 160 - 163
  • [50] DANAZOL FOR CHILDREN WITH IMMUNE THROMBOCYTOPENIC PURPURA
    WEINBLATT, ME
    KOCHEN, J
    ORTEGA, J
    AMERICAN JOURNAL OF DISEASES OF CHILDREN, 1988, 142 (12): : 1317 - 1319